July 20, 2020

Cannabis Found Effective to Treat Sickle Cell Disease Pain

July 20, 2020
Medical Marijuana

Cannabis appears to be a safe and potentially effective treatment for the chronic pain that afflicts people with sickle cell disease, according to a new clinical trial co-led by University of California, Irvine (UCI) researcher Kalpna Gupta and Dr. Donald Abrams of UC San Francisco.

The study’s results, released July 17, 2020, could have wide-reaching ramifications in that opioids are currently the primary treatment to ease the chronic and acute pain suffered by those afflicted with sickle cell disease (SCD).

SCD is a common inherited blood disorder, also called sickle cell anemia in its more serious stage. The disease affects an estimated 70,000 to 100,000 Americans.

The only cure for SCD is bone marrow or stem cell transplant, according to the Centers for Disease Control (CDC).

The rise in opioid-related deaths and addiction has prompted physicians to prescribe them less frequently, thereby leaving sickle cell patients with fewer and fewer treatment options.

Sickle Cell Disease and Cannabis

“These trial results show that vaporized cannabis appears to be generally safe,” researcher Kalpna Gupt, a professor of medicine on the faculty of University of California Irvine’s Center for the Study of Cannabis.

Gupta said that, in addition to the study at hand, the trial opened the door for testing different forms of medical cannabis to treat chronic pain, including vaporized forms, which is what they used in the study. He noted that treating pain is the top reason people cite for seeking cannabis from dispensaries. 

“They [the trials] also suggest that sickle cell patients may be able to mitigate their pain with cannabis – and that cannabis might help society address the public health crisis related to opioids. Of course, we still need larger studies with more participants to give us a better picture of how cannabis could benefit people with chronic pain.”

The double-blind, placebo-controlled, randomized trial was the first to employ such gold-standard methods to assess cannabis’s potential for pain alleviation in people with sickle cell disease, noted a press release from UCI’s Center for the Study of Cannabis.

Researchers assessed participants’ pain levels throughout the treatment period and found that the effectiveness of cannabis, which contained equal parts THC and CBD, appeared to increase over time.

As the five-day study period progressed, the twenty three subjects reported that pain interfered less and less with their activities, including walking and sleeping, and there was a statistically significant drop in how much pain affected their mood.

The findings appear in JAMA Network Open.


Share on facebook
Share on twitter
Share on pinterest
Share on reddit
Recent & Related Posts


Recent & Related Posts
Image of weed plant: Missouri has legal medical marijuana and is close to legalizing adult use cannabis.
Travis Maurer

Missouri Marijuana

Medical marijuana has been legalized in Missouri since 2018. As of the current date, recreational marijuana has yet to be legalized, however we are holding

Read More »
MisImage of Missouri medical marijuana program, but some patients have received fraudulent doctors' patient certifications.
Mark Willey

Missouri Medical Cannabis

Does Missouri Have Medical Cannabis? Yes. After voters passed Amendment 2 by an overwhelming margin in November 2018., Missouri voters showed their support behind MO

Read More »
Mark Willey

Missouri Green Doctors

Since voters passed Amendment 2 with an overwhelming majority in 2018, Missouri has become a new medical marijuana landscape and has seen approximately 50,000 patients

Read More »
Ryan Quinones

Hemp Missouri

Missourians have been growing hemp as a staple crop dating back to the early-nineteenth century. American farmers grew hemp all over the country and manufactured

Read More »